Search clinical trials for: Placebo Olanzapine

Total 53868 results

Teva Pharmaceuticals USA

Completed

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

Healthy

United States
Eli Lilly and Company

Completed

A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients

Bipolar I Disorder

United States
Eli Lilly and Company

Completed

Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder

Bipolar Disorder

Japan
Eli Lilly and Company

Completed

An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.

Schizophrenia | Bipolar Disorder

Germany, Greece, France
Eli Lilly and Company

Completed

Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia

Schizophrenia

Japan
Kunming Medical University
National Natural Science Foundation of China

Completed

5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia

Early-onset Schizophrenia

China
Tadashi Hasegawa

Completed

Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)

Bipolar Disorder

Japan
Beijing HuiLongGuan Hospital

Completed

The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia

Schizophrenia
University of Minnesota
Eli Lilly and Company

Completed

PET Imaging and Olanzapine Treatment in Borderline Personality Disorder

Borderline Personality Disorder

United States
Drexel University
National Institute of Mental Health (NIMH)

Completed

Long-Term Olanzapine Treatment in Children With Autism

Autism

United States
Shalvata Mental Health Center

Unknown

A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorders

Israel
China Medical University, China

Completed

Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression

Bipolar Disorder | Depression, Bipolar

China
Eli Lilly and Company

Completed

A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

Weight Gain

Italy
Boehringer Ingelheim

Completed

SITS-IVT in Patients >80 Years Study (SITS_ELDERLY)

Ischaemic Stroke

Sweden
Xingchen Peng

Recruiting

Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV

Chemotherapy-induced Nausea and Vomiting

China
Rush University Medical Center

Completed

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Nausea | Vomiting

United States
Eli Lilly and Company

Completed

Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet (PREFERENCE)

Schizophrenia

Turkey, Brazil, Romania
Khon Kaen University

Unknown

Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care

Nausea | Vomiting | End Stage Cancer

Thailand
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.

Schizophrenia

United States
Organon and Co

Completed

6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)

Schizophrenia
VA Connecticut Healthcare System
Eli Lilly and Company; Clinical Trials Network of Columbia U, Cornell U, and...

Withdrawn

Zyprexa and Task Engagement in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Pharmacokinetic Characterization of Intramuscular Olanzapine Depot

Schizophrenia | Schizoaffective Disorder

Australia, Belgium, Brazil, Croatia, Czech Republic, Mexico, Slovakia, Spain
Organon and Co

Completed

6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)

Schizophrenia
Stanford University
Eli Lilly and Company

Completed

Short Term Rescue Study of Olanzapine

Bipolar Disorder

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

Schizophrenia, Schizoaffective Disorder

United States
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fasting Condition

Healthy

India
Children's Hospital of Eastern Ontario

Terminated

Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and Adolescents

Eating Disorder

Canada
Lindner Center of HOPE
Eli Lilly and Company; University of Cincinnati

Completed

Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling

Pathological Gambling

United States
Eli Lilly and Company

Completed

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Bipolar Disorder I or II

France
Eli Lilly and Company

Completed

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Bipolar Depression

Russian Federation, United States
Lindner Center of HOPE
Eli Lilly and Company; University of Cincinnati

Completed

A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain

Weight Gain

United States
Sun Yat-sen University
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study (OFFER)

Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy

China
Organon and Co

Completed

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)

Schizophrenia
Kaohsiung Kai-Suan Psychiatric Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)

Completed

Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine

Schizophrenia

Taiwan
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition

Healthy

India
Eli Lilly and Company

Completed

Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

Schizophrenic Disorders

Korea, Republic of
Alkermes, Inc.

Completed

Study of the Breast Milk Pharmacokinetics of Olanzapine and Samidorphan

Focus of Study is on Healthy Lactating Women

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition

Fasting

India
Hamilton Health Sciences Corporation
AstraZeneca

Completed

Cognition, Functioning and Quality of Life

Schizophrenia

Canada
University Hospital, Basel, Switzerland

Recruiting

Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects (LBL)

Healthy

Switzerland
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia

Schizophrenia

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia

Schizophrenia

China
Eli Lilly and Company

Completed

Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder

Schizoaffective Disorder | Schizophrenic Disorders

United States, France, Italy, Belgium, Mexico, Russian Federation, Puerto Rico, Taiwan, Australia, Romania, Croatia, Germany, Poland, Spain, Argentina, Brazil, Portugal, Slovakia, South Africa, Israel, Hungary, Austria, Czech Republic, Netherlan... and more
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition

Fed

India
University Health Network, Toronto

Unknown

Acute Olanzapine and Lipid Response (OLA)

Healthy

Canada
University of Florida
National Institute of Mental Health (NIMH)

Completed

Treatment of Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

United States
Tanta University

Not yet recruiting

Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients

Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
Mylan Pharmaceuticals Inc

Completed

Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Terminated

Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg

Healthy

United States
Eli Lilly and Company

Completed

Olanzapine Versus Comparator in the Treatment of Bipolar Disorder

Bipolar Disorder

China

3

Subscribe